Robin Leaper lost her voice to ALS. Artificial Intelligence has given her back the ability to speak with her own voice.

Due to a lack of resources and personnel, the FDA has delayed until October its decision on lifting a clinical hold on ALS ...

Neurizon Therapeutics’ disease-modifying drug NUZ-001 has been shown to be safe and effective over 2.5 years of dosing in ...

Australia’s Neurizon Therapeutics, a biotech advancing innovative treatments for neurodegenerative diseases, has reported positive top-line results from the Open-Label Extension (OLE) study of its ...

A strong performance from APA’s gas transmission and storage business contributed to a 6.4% lift in EBITDA for the company, ...

A physical fitness challenge named the “Pete and Bobby Challenge” was held on the 19th at a massive gym facility in the U.S.

The Driving and Vehicle Licensing Agency (DVLA) could slap drivers with a £1,000 fine if they fail to report certain health ...

Host Tylah Tully is joined in this episode by Argenica Therapeutics (ASX:AGN) managing director Dr Liz Dallimore, who shares ...

DelveInsight's HDAC Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

The ketamine product KETARx produced by PharmaTher has been approved by the FDA for use in surgical pain management.

Family, friends and colleagues braved the heat early Friday evening to pay respect to the late Brent McGee, the former ...